Medpace Continues to Grow in Europe
News Aug 19, 2015
The new office is roughly three times the size of the former facility, allowing for significant growth in Data Management, Bio Statistics, Quality Assurance, Regulatory Affairs, Clinical Operations, and Safety. Together with the recently expanded London office, Medpace continues to invest in additional capacity for our operations globally. The UK offices in London and Stirling, Scotland, now houses close to 130 Medpace employees.
Medpace has focused expansion efforts in Europe over the past few years. The European activities have included adding additional clinical research professionals and expanding facilities in the United Kingdom, Poland, Russia, France, Germany and future significant office expansions planned for 2015/2016 in Leuven (Belgium), Prague (Czech Republic), Madrid (Spain). Medpace offices in Europe offer clinical operational support for a rapidly expanding Global and European market. Medpace established its first European office in the Czech Republic in 2005. Medpace employees in Europe now account for over one third of Medpace global employees.
With 12 European offices serving 30 EU countries, Medpace continues to grow and supply innovative support for studies in oncology, cardio metabolic, infectious disease, CNS, and other growing therapeutic areas. All European offices are fully integrated with Medpace global development services.
Anti-Inflammatory Pill Could Make Vaccines More Effective for the ElderlyNews
By identifying why skin immunity declines in old age, a UCL-led research team has found that an anti-inflammatory pill could help make vaccines more effective for elderly people.READ MORE
BIA Separations appoints Pete Gagnon as Chief Scientific OfficerNews
Appointment will drive new product and applications development.READ MORE